15.16
-0.25 (-1.59%)
| Previous Close | 15.40 |
| Open | 15.40 |
| Volume | 9,605,294 |
| Avg. Volume (3M) | 11,893,690 |
| Market Cap | 10,331,749,376 |
| Price / Earnings (TTM) | 15.00 |
| Price / Earnings (Forward) | 13.93 |
| Price / Sales | 1.41 |
| Price / Book | 1.49 |
| 52 Weeks Range | |
| Earnings Date | 29 Oct 2025 |
| Profit Margin | 10.70% |
| Operating Margin (TTM) | 8.21% |
| Diluted EPS (TTM) | 1.04 |
| Quarterly Revenue Growth (YOY) | -5.90% |
| Quarterly Earnings Growth (YOY) | 6.80% |
| Total Debt/Equity (MRQ) | 67.34% |
| Current Ratio (MRQ) | 1.12 |
| Operating Cash Flow (TTM) | 808.50 M |
| Levered Free Cash Flow (TTM) | 751.08 M |
| Return on Assets (TTM) | 3.53% |
| Return on Equity (TTM) | 12.52% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Instruments & Supplies (US) | Bullish | Mixed |
| Medical Instruments & Supplies (Global) | Bullish | Mixed | |
| Stock | Avantor, Inc. | Mixed | Bearish |
AIStockmoo Score
| Analyst Consensus | -1.5 |
| Insider Activity | 1.5 |
| Price Volatility | -2.0 |
| Technical Moving Averages | -1.0 |
| Technical Oscillators | -0.5 |
| Average | -0.70 |
|
Avantor Inc provider of products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company has three geographic segments: the Americas, Europe, and AMEA. The company's product group consists of Equipment & instrumentation, Services & specialty procurement, Proprietary materials & consumables, and Third-party materials & consumables. Materials & consumables include high-purity chemicals and reagents, lab products and supplies, specialized formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, and education and microbiology and clinical trial kits, peristaltic pumps and fluid handling tips. |
|
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Investment Style | Small Value |
| % Held by Insiders | 1.35% |
| % Held by Institutions | 103.17% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| New Mountain Capital, L.L.C. | 30 Jun 2025 | 14,000,000 |
| Robeco Schweiz Ag | 30 Sep 2025 | 7,920,177 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 17.00 (RBC Capital, 12.17%) | Buy |
| 17.00 (Baird, 12.17%) | Buy | |
| Median | 14.00 (-7.62%) | |
| Low | 12.00 (Barclays, -20.82%) | Hold |
| 12.00 (JP Morgan, -20.82%) | Hold | |
| 12.00 (Stifel, -20.82%) | Hold | |
| 12.00 (Morgan Stanley, -20.82%) | Hold | |
| Average | 14.22 (-6.17%) | |
| Total | 5 Buy, 4 Hold | |
| Avg. Price @ Call | 12.04 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Barclays | 30 Oct 2025 | 12.00 (-20.82%) | Hold | 11.05 |
| 02 Oct 2025 | 15.00 (-1.02%) | Buy | 13.77 | |
| Evercore ISI Group | 30 Oct 2025 | 14.00 (-7.62%) | Buy | 11.05 |
| 04 Aug 2025 | 16.00 (5.58%) | Buy | 11.30 | |
| JP Morgan | 30 Oct 2025 | 12.00 (-20.82%) | Hold | 11.05 |
| 04 Aug 2025 | 14.00 (-7.62%) | Buy | 11.30 | |
| Baird | 24 Oct 2025 | 17.00 (12.17%) | Buy | 15.40 |
| 04 Aug 2025 | 15.00 (-1.02%) | Buy | 11.30 | |
| Raymond James | 16 Oct 2025 | 16.00 (5.58%) | Buy | 14.57 |
| 04 Aug 2025 | 14.00 (-7.62%) | Buy | 11.30 | |
| Morgan Stanley | 04 Aug 2025 | 12.00 (-20.82%) | Hold | 11.30 |
| RBC Capital | 04 Aug 2025 | 17.00 (12.17%) | Buy | 11.30 |
| Stifel | 04 Aug 2025 | 12.00 (-20.82%) | Hold | 11.30 |
| Wells Fargo | 04 Aug 2025 | 16.00 (5.58%) | Buy | 11.30 |
| Show more | ||||
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| SUMME GREGORY L | 11.05 | - | 100,000 | 1,105,000 |
| Aggregate Net Quantity | 100,000 | |||
| Aggregate Net Value ($) | 1,105,000 | |||
| Aggregate Avg. Buy ($) | 11.05 | |||
| Aggregate Avg. Sell ($) | - | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| SUMME GREGORY L | Director | 30 Oct 2025 | Buy (+) | 100,000 | 11.05 | 1,105,000 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |